Finance

Lists
PRAX:NASDAQ
Praxis Precision Medicines Inc
၂၉၁.၄၆ US$
+၁.၅၈%
(+၄.၅၄) 1D
အောက် ၂, GMT-၄ ၁၁:၃၄:၃၉  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRAX...
Open
၂၉၀.၁၃ US$
High
၂၉၅.၅၀ US$
Low
၂၈၆.၀၀ US$
Mkt. cap
၈၁၃.၇၄ ဋေ
Avg. vol.
၄.၁၂ သိန်း
Volume
၇.၆၇ သောင်း
52-wk high
၃၉၂.၇၀ US$
52-wk low
၅၀.၃၁ US$
EPS
-၁၂.၉၃ US$
Beta
၂.၇၉
Shares outstanding
၂.၇၉ ကုဋေ
No. of employees
၁၆၈
Open
၂၉၀.၁၃ US$
High
၂၉၅.၅၀ US$
Low
၂၈၆.၀၀ US$
Mkt. cap
၈၁၃.၇၄ ဋေ
Avg. vol.
၄.၁၂ သိန်း
Volume
၇.၆၇ သောင်း
52-wk high
၃၉၂.၇၀ US$
52-wk low
၅၀.၃၁ US$
EPS
-၁၂.၉၃ US$
Beta
၂.၇၉
Shares outstanding
၂.၇၉ ကုဋေ
No. of employees
၁၆၈
News stories
From web sources and news partners
巴士的報
巴士的報
·
ပြီးခဲ့သည့် ၁ နာရီ
New York Giants at NYSE for 40th Anniv. of Super Bowl XXI: NYSE Content Update
Foreign Policy Journal
Foreign Policy Journal
·
ပြီးခဲ့သည့် ၂၁ မိနစ်
Bitmine Immersion Technologies (NASDAQ: BMNR) Forms Golden Cross As Ethereum Holdings Surpass 6 Million Tokens
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၈ မိနစ်
Comcast (NASDAQ:CMCSA) Given New $27.50 Price Target at Scotiabank
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂၅ မိနစ်
1 S&P 500 Stock to Research Further and 2 Facing Headwinds
About Praxis Precision Medicines Inc
CEO-
Employees၁၆၈
Founded၂၀၁၅
Headquartersဘော့စတွန်မြို့, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitepraxismedicines.com
Analyst ratings
Based on 14 analysts giving stock ratings to PRAX in the past 3 months
Strong buy
Buy
13
Hold
1
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for PRAX in the last 3 months.
Highest
Current ၂၉၁.၄၆ US$
၁,၂၀၁.၀၀ US$ (+၃၁၂.၀၇%)
Average
၆၉၃.၂၁ US$ (+၁၃၇.၈၄%)
Lowest
၃၆၂.၀၀ US$ (+၂၄.၂၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Justin Walsh
JonesTrading
Buy
Reiterated
၅၃၄.၀၀ US$
+၈၃.၂%
10/01/2026
Douglas Tsao
H.C. Wainwright
Buy
Maintained
၁,၂၀၁.၀၀ US$
+၃၁၂.၁%
09/24/2026
Ami Fadia
Needham
Buy
Reiterated
၅၈၂.၀၀ US$
+၉၉.၇%
09/24/2026
Kevin Strang
Goldman Sachs
Buy
Reiterated
၅၇၅.၀၀ US$
+၉၇.၃%
08/21/2026
Jay Olson
Oppenheimer
Buy
Reiterated
၆၅၀.၀၀ US$
+၁၂၃%
08/17/2026
Tiago Fauth
Raymond James
Buy
Maintained
၉၄၅.၀၀ US$
+၂၂၄.၂%
08/17/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
၁,၂၀၀.၀၀ US$
+၃၁၁.၇%
08/07/2026
Danielle Brill
Truist Financial
Buy
Maintained
၆၁၆.၀၀ US$
+၁၁၁.၄%
08/07/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
၈၀၀.၀၀ US$
+၁၇၄.၅%
08/06/2026
Brian Skorney
Robert W. Baird
Buy
Maintained
၅၁၄.၀၀ US$
+၇၆.၄%
08/07/2026
Leonid Timashev
RBC Capital
Buy
Reiterated
၄၆၂.၀၀ US$
+၅၈.၅%
08/06/2026
Benjamin Burnett
Wells Fargo
Hold
Maintained
၃၆၂.၀၀ US$
+၂၄.၂%
08/07/2026
Ritu Baral
TD Cowen
Buy
Maintained
၅၁၀.၀၀ US$
+၇၅%
08/06/2026
Francois Brisebois
LifeSci Capital
Buy
Reiterated
၇၅၄.၀၀ US$
+၁၅၈.၇%
08/08/2026
Andrew Tsai
Jefferies
Buy
Maintained
၅၅၀.၀၀ US$
+၈၈.၇%
06/30/2026
Kambiz Yazdi
BTIG
Buy
Maintained
၈၁၀.၀၀ US$
+၁၇၇.၉%
06/29/2026
Laura Chico
Wedbush
Sell
Maintained
၁၆၂.၀၀ US$
-၄၄.၄%
06/02/2026
David Hoang
Deutsche Bank
Buy
Maintained
၃၇၄.၀၀ US$
+၂၈.၃%
06/02/2026
Joon Lee
Truist Financial
Buy
Initiated
၇၁၅.၀၀ US$
+၁၄၅.၃%
05/13/2026
Unknown Analyst
Raymond James
Buy
Initiated
၈၁၅.၀၀ US$
+၁၇၉.၆%
04/08/2026
Rudy Li
Wolfe Research
Buy
Maintained
၅၀၀.၀၀ US$
+၇၁.၆%
04/06/2026
Last report
၂၀၂၆ ဩ ၆
Fiscal period
Q2 2026
EPS / Est. (USD)
-၂.၈၇ US$ / -၃.၆၉ US$
+၂၂.၂၂%beat
Revenue / Est. (USD)
- / ၀.၀၀
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
၆.၅၈ ကုဋေ
၇.၇၅ ကုဋေ
၇.၈၀ ကုဋေ
၆.၉၄ ကုဋေ
Cost of revenue
၆.၅၈ ကုဋေ
၇.၇၅ ကုဋေ
၇.၈၀ ကုဋေ
၆.၉၄ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၂၆ ကုဋေ
၁.၉၅ ကုဋေ
၂.၇၉ ကုဋေ
၂.၇၅ ကုဋေ
Operating expense
၁.၂၆ ကုဋေ
၁.၉၅ ကုဋေ
၂.၇၉ ကုဋေ
၂.၇၅ ကုဋေ
Total operating expenses
၇.၈၄ ကုဋေ
၉.၇၀ ကုဋေ
၁၀.၅၉ ကုဋေ
၉.၆၉ ကုဋေ
Operating income
-၇.၈၄ ကုဋေ
-၉.၇၀ ကုဋေ
-၁၀.၅၉ ကုဋေ
-၉.၆၉ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၇.၃၉ ကုဋေ
-၈.၈၉ ကုဋေ
-၉.၂၆ ကုဋေ
-၈.၃၇ ကုဋေ
EBT excluding unusual items
-၇.၃၉ ကုဋေ
-၉.၂၅ ကုဋေ
-၉.၃၂ ကုဋေ
-၈.၃၇ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၇.၃၉ ကုဋေ
-၈.၈၉ ကုဋေ
-၉.၂၆ ကုဋေ
-၈.၃၇ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၃.၃၆
-၃.၅၀
-၃.၂၀
-၂.၈၇
Interest and investment income
၄.၄၂ သန်း
၄.၅၄ သန်း
၁.၂၆ ကုဋေ
၁.၃၂ ကုဋေ
Interest expense
-
-
-
-
Net interest expenses
၄.၄၂ သန်း
၄.၅၄ သန်း
၁.၂၆ ကုဋေ
၁.၃၂ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
-၇.၈၃ ကုဋေ
-၉.၇၀ ကုဋေ
-၁၀.၅၈ ကုဋေ
-၉.၆၉ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google အက်ပ်များ